Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats

Cardiovascular Research

Volumn 31, Issue 2, 1996, Pages 287-295

  Karam, Habib ^a   Heudes, Didier ^b   Hess, Patrick ^a   Gonzales, Marie Françoise ^c   Löffler, Bernd Michael ^a   Clozel, Martine ^a   Clozel, Jean Paul ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b HÔPITAL BROUSSAIS   (France)

^c INSERM   (France)

Author keywords

Calcium antgonists; Endothelin receptor antagonists; Hypertension; Hypertrophy; Rat

Indexed keywords

BOSENTAN; CALCIUM ANTAGONIST; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN RECEPTOR ANTAGONIST; MIBEFRADIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; CALCIUM CHANNEL BLOCKERS; CARDIOMEGALY; COLLAGEN; CORONARY CIRCULATION; DESOXYCORTICOSTERONE; ENALAPRIL; FIBROSIS; HYPERTENSION; MALE; MIBEFRADIL; MYOCARDIUM; PERFUSION; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; SULFONAMIDES; TETRAHYDRONAPHTHALENES;

EID: 0029914353     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00201-4     Document Type: Article

References (53)

1. Frohlich ED. Hemodynamics and other determinants in development of left ventricular hypertrophy. Fed Proc 1983;42:2709-2715.
2. Wicker P, Tarazi RC, Kobayashi K. Coronary blood flow during the development and regression of left ventricular hypertrophy in renovascular hypertensive rats. Am J Cardiol 1983;51:1744-1749.
3. Yamamoto J, Tsuchia M, Saito M, Ikeda M. Cardiac contractile and coronary flow reserves in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1985;7:569-577.
4. Pearlman ES, Weber KT, Janicki JS, Pietra GG, Fishman AP. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982;46:158-164.
5. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988;62:757-765.
6. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67:1355-1364.
7. Sen S, Tarazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 1974;35:775-781.
8. Tsoporis J, Leenen FHH. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension 1988;11: 376-386.
9. Ruzicka M, Yuan B, Harmsen E, Leenen FHH. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats: effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation 1993;87:921-930.
10. Pfeffer FM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci USA 1982;79:3310-3317.
11. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
12. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 1993;27:2130-2134.
13. Clozel J-P, Kuhn H, Hefti F. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 1989;7:267-275.
14. Clozel JP, Hefti F. Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1988;11:568-572.
15. Clozel J-P, Véniant M, Hess P, Sprecher U. Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats. Hypertension 1991;18(suppl. II):II-8-II-14.
16. Jalil JE, Janicki JS, Pick R, Weber KT. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: response to captopril. Am J Hypertens 1991;4:51-55.
17. Erdös EG. Angiotensin I converting enzyme. Circ Res 1975;36:247-255.
18. Ito H, Hirata Y, Hiroe M, et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991;69:209-215.
19. Ho H, Hirata Y, Adachi S, et al. Endothelin is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993;92:398-403.
20. Guarda E, Myers PR, Brilla CG, Tyagi SC, Weber KT. Endothelial cell induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc Res 1993;27:1004-1008.
21. Ueno Y, Mohara O, Brosnihan KB, Ferrario CM. Characteristics of hormonal and neurogenic mechanisms of deoxycorticosterone-induced hypertension. Hypertension 1988;11(suppl. I):I172-I177.
22. Hamlyn JM, Blaustein MP. Sodium chloride, extracellular fluid volume and blood pressure regulation. Am J Physiol 1986;251: F563-F575.
23. Clozel JP, Osterrieder W, Kleinbloesem CH, et al. Ro 40-5967: a new nondihydropyridine calcium antagonist. Cardiovasc Drugs Rev 1991;9:4-17.
24. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-235.
25. Véniant M, Clozel J-P, Heudes D, Banken L, Ménard J. Effects of Ro 40-5967, a new calcium antagonist and enalapril on cardiac remodeling in renal hypertensive rats. J Cardiovasc Pharmacol 1993;21:544-551.
26. Löffler B-M, Maire J-P. Radioimmunological determination of endothelin peptides in human plasma: a methodological approach. Endothelium 1994;1:273-286.
27. Ménard J, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 1972;90:422-430.
28. Junqueira LCU, Cossermelli W, Brentani R. Differential staining of collagens type I, II and III by Sirius red and polarization microscopy. Arch Histol Jpn 1978;41:267-274.
29. Hoyt RH, Ericksen E, Collins SM, Skorton DJ. Computer-assisted quantitation of myocardial fibrosis in histologic sections. Arch Pathol Lab Med 1984;108:280-283.
30. Ménard J, Guyene TT, Chatellier G, Kleinbloesem CH, Bernadet P. Renin release regulation during acute renin inhibition in normal volunteers. Hypertension 1991;18:257-265.
31. Löffler B-M, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 in endothelin levels in rat plasma. FEBS Lett 1993;333: 108-110.
32. B receptors in rats. Biochem Biophys Res Commun 1994;199:1461-1465.
33. Hoffmann JIE. A critical view of coronary reserve. Circulation 1987;75(suppl. I):1-6.
34. Silver MA, Pick R, Brilla CG, Jalil JE, Janicki JS, Weber KT. Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricule: two experimental models of myocardial fibrosis. Cardiovasc Res 1990;24:741-747.
35. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 1994;93:2578-2583.
36. Ito H, Hiroe M, Hirata Y, et al. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994;89:2198-2203.
37. Suzuki T, Kumazaki T, Mitsui Y. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 1993;191:823-830.
38. Hori S, Komatsu Y, Shigemoto R, Mizuno N, Nakanishi S. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 1992;130:1885-1895.
39. Shubeita HE, McDonough PM, Harris AN, et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 1990;265: 20555-20562.
40. Medugorac I. Collagen content in different areas of normal and hypertrophied rat myocardium. Cardiovasc Res 1980;14:551-554.
41. Michel JB, Salzmann JL, Ossondo NM, Bruneval P, Barres D, Camilleri JP. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol 1986;81:142-154.
42. Hirata Y, Tagaki Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225-228.
43. Kahaleh MB. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum 1991;34:978-983.
44. Katwa LC, Guarda E, Weber KT. Endothelin receptors in cultured adult rat cardiac fibroblasts. Cardiovasc Res 1993;27:2125-2129.
45. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-820.
46. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993;88:2849-2861.
47. Campbell DJ, Kladis A, Duncan A-M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994;23:439-449.
48. Sun Y, Weber KT. Bradykinin receptors and myocardial fibrosis in the rat with either primary or secondary hyperaldosteronism. (Abstract). Am J Hypertens 1993;6:12A.
49. Sun Y, Diaz-Arias A, Weber KT. Angiotensin converting enzyme, bradykinin and angiotensin II receptor binding in rat skin, tendon and heart valves: an in vitro quantitative autoradiographic study. J Lab Clin Med 1994;123:372-377.
50. Kawaguchi H, Sawa H, Yasuda H. Effect of endothelin on angiotensin converting enzyme activity in cultured pulmonary artery endothelial cells. J Hypertens 1991;9:171-174.
51. Emori T, Hirata Y, Ohta K, Shichiri M, Marumo F. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 1989;160:93-100.
52. Chua BHL, Chua CC, Diglio CA, Siu BB. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1993;1178:201-206.
53. B receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem Biophys Res Commun 1993;194:1282-1287.